Braskem (BAK) to Release Earnings on Thursday

Braskem (NYSE:BAK - Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 8th. Analysts expect Braskem to post earnings of $0.06 per share and revenue of $22.86 billion for the quarter.Braskem: A Green Investment in the Bioplastics MarketBraskem (NYSE:BAK - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.01). Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%. The firm had revenue of $3.28 billion during the quarter, compared to analyst estimates of $3.52 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year. Braskem Stock Down 5.8 %NYSE:BAK opened at $3.71 on Thursday. Braskem has a 12-month low of $2.85 and a 12-month high of $9.05. The firm has a 50-day moving average price of $3.68 and a 200 day moving average price of $4.47. The firm has a market capitalization of $1.48 billion, a PE ratio of -1.05 and a beta of 1.80. Analysts Set New Price TargetsSeparately, Scotiabank lowered shares of Braskem from a "sector outperform" rating to a "sector perform" rating in a report on Monday, March 3rd.Get Our Latest Stock Analysis on BraskemBraskem Company Profile (Get Free Report)Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.See AlsoFive stocks we like better than BraskemUsing the MarketBeat Stock Split CalculatorWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumComparing and Trading High PE Ratio StocksHims & Hers Stock Soars on Novo Nordisk CollaborationWhy Invest in 5G? How to Invest in 5G Stocks Amazon's Earnings Will Make or Break the Stock's Comeback This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Braskem Right Now?Before you consider Braskem, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here